Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Study Evaluating the Safety and Efficacy of Targeted Therapies in Subpopulations of Patients With Metastatic Colorectal Cancer (INTRINSIC)

Multiple Cancer Types

This open-label, exploratory study is designed to evaluate the safety and efficacy of
targeted therapies or immunotherapy as single agents or combinations, in participants with
metastatic colorectal cancer (mCRC) whose tumors are biomarker positive as per treatment
arm-specific definition. Eligible participants with mCRC will be enrolled into specific
treatment arms based on their biomarker assay results.
Colon, Phase I, Rectal
I
Ciombor, Kristen
NCT04929223
VICCGIP2158

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: